Qiuhua Lai

Nanfang Hospital — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

21h-index1.6kcitations53works20.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer-related molecular mechanisms research(16), RNA regulation and disease(10), Epigenetics and DNA Methylation(9), RNA modifications and cancer(9), NF-κB Signaling Pathways(9)

Publications53 total

Comprehensively prognostic and immunological analyses of GLP-1 signaling-related genes in pan-cancer and validation in colorectal cancer
Frontiers in Pharmacology·2024· 15 citedOpen Access
Adipose-derived stem cells promote glycolysis and peritoneal metastasis via TGF-β1/SMAD3/ANGPTL4 axis in colorectal cancer
Cellular and Molecular Life Sciences·2024· 26 citedOpen Access
RUNX1 promotes angiogenesis in colorectal cancer by regulating the crosstalk between tumor cells and tumor associated macrophages
Biomarker Research·2024· 21 citedOpen Access
Integrated analyses reveal the prognostic and immunotherapeutic value of endoplasmic reticulum stress-related genes in cancer
Genes & Diseases·2023· 1 citedOpen Access
LIMK1 m6A-RNA methylation recognized by YTHDC2 induces 5-FU chemoresistance in colorectal cancer via endoplasmic reticulum stress and stress granule formation
Cancer Letters·2023· 34 cited
Figure S1 from Downregulation of <i>SAFB</i> Sustains the NF-<b>κ</b>B Pathway by Targeting <i>TAK1</i> during the Progression of Colorectal Cancer
2023Open Access
Figure S3 from Downregulation of <i>SAFB</i> Sustains the NF-<b>κ</b>B Pathway by Targeting <i>TAK1</i> during the Progression of Colorectal Cancer
2023Open Access
Data from Downregulation of <i>SAFB</i> Sustains the NF-<b>κ</b>B Pathway by Targeting <i>TAK1</i> during the Progression of Colorectal Cancer
2023Open Access
Supplementary materials, methods and tables from Downregulation of <i>SAFB</i> Sustains the NF-<b>κ</b>B Pathway by Targeting <i>TAK1</i> during the Progression of Colorectal Cancer
2023Open Access
Figure S4 from Downregulation of <i>SAFB</i> Sustains the NF-<b>κ</b>B Pathway by Targeting <i>TAK1</i> during the Progression of Colorectal Cancer
2023Open Access
Figure S5 from Downregulation of <i>SAFB</i> Sustains the NF-<b>κ</b>B Pathway by Targeting <i>TAK1</i> during the Progression of Colorectal Cancer
2023Open Access
Figure S3 from Downregulation of <i>SAFB</i> Sustains the NF-<b>κ</b>B Pathway by Targeting <i>TAK1</i> during the Progression of Colorectal Cancer
2023Open Access
Figure S2 from Downregulation of <i>SAFB</i> Sustains the NF-<b>κ</b>B Pathway by Targeting <i>TAK1</i> during the Progression of Colorectal Cancer
2023Open Access
Data from Downregulation of <i>SAFB</i> Sustains the NF-<b>κ</b>B Pathway by Targeting <i>TAK1</i> during the Progression of Colorectal Cancer
2023Open Access
Figure S2 from Downregulation of <i>SAFB</i> Sustains the NF-<b>κ</b>B Pathway by Targeting <i>TAK1</i> during the Progression of Colorectal Cancer
2023Open Access
Figure S1 from Downregulation of <i>SAFB</i> Sustains the NF-<b>κ</b>B Pathway by Targeting <i>TAK1</i> during the Progression of Colorectal Cancer
2023Open Access
Figure S6 from Downregulation of <i>SAFB</i> Sustains the NF-<b>κ</b>B Pathway by Targeting <i>TAK1</i> during the Progression of Colorectal Cancer
2023Open Access
Figure S4 from Downregulation of <i>SAFB</i> Sustains the NF-<b>κ</b>B Pathway by Targeting <i>TAK1</i> during the Progression of Colorectal Cancer
2023Open Access
Figure S5 from Downregulation of <i>SAFB</i> Sustains the NF-<b>κ</b>B Pathway by Targeting <i>TAK1</i> during the Progression of Colorectal Cancer
2023Open Access
Supplementary materials, methods and tables from Downregulation of <i>SAFB</i> Sustains the NF-<b>κ</b>B Pathway by Targeting <i>TAK1</i> during the Progression of Colorectal Cancer
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Side Liu(24), Chun-Cai Gu(22), Yaping Ye(20), Yanqing Ding(20), Liuqing He(18), Wenting Liao(18), Yuxin Fang(16), Qingyuan Li(15), Aimin Li(15), Runwei Yang(15), Yong‐Xia Wang(15), Yanru Chen(15), Yue-Long Cai(15), Yun-Teng Hu(15), Junfeng Qiu(15), Guangwen Cao(15), Chengcheng He(14), Huiying Sun(14), Zhi-Yuan Xiao(14), Juan-Juan Cai(14)